Nerandomilast

Nerandomilast, sold under the brand name Jascayd, is a medication used for the treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. It is a phosphodiesterase 4 (PDE4) inhibitor. It is taken by mouth.

Nº Q136594966 ★★

Peu commune · Savoirs

Nerandomilast

Texte en anglais

Nerandomilast, sold under the brand name Jascayd, is a medication used for the treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. It is a phosphodiesterase 4 (PDE4) inhibitor. It is taken by mouth.

Dernier prix

—

Prix plancher

—

Médiane 7 j

—

Ventes 30 j

0

Fourchette 30 j

—

En circulation

0

Cours

Voir le tableau
Datemédiane MinMaxventes

Historique des ventes

Dernière vente
—
Moyenne 30 j
—
Plus bas 30 j
—
Plus haut 30 j
—
Ventes 7 j
0
Ventes 30 j
0

Aucune vente pour l'instant.

Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.

Sur Wikipédia

Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.

Nerandomilast, sold under the brand name Jascayd, is a medication used for the treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. It is a phosphodiesterase 4 (PDE4) inhibitor. It is taken by mouth. Common side effects include diarrhea, decreased weight, decreased appetite, and nausea. Nerandomilast was approved for medical use in the United States in October 2025. The US Food and Drug Administration considers it to be a first-in-class medication.

Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : Vaccinationist (Public domain) ·

Cartes voisines

Voir la fiche

Confirmation